Asia
Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement
Tiansheng Pharmaceutical (SHE:002872) said three of its products are proposed for selection in China's national centralized procurement of Chinese patent medicines.These include the company's jianwei xiaoshi tablets, along with its subsidiary's ganmao qingre granules and tenghuang jiangu pills, according to a Friday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 3% higher Friday.
SHE:002872
